世界の動物用感染症治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Veterinary Infectious Diseases Therapeutics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X15136 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、動物用感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。動物用感染症治療薬の種類別市場規模（抗生物質、抗ウイルス剤、抗真菌剤、殺虫剤、駆虫剤）、用途別市場規模（豚、鶏肉、犬、猫、牛、馬、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・動物用感染症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Elanco Animal Health、Novartis Animal Health、Merck、Pfizer Animal Health、Sanofi、Boehringer Ingelheim Vetmedica、Dechra Animal Health、Ceva Sante Animale、Elanco Animal Health、Virbac ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗生物質、抗ウイルス剤、抗真菌剤、殺虫剤、駆虫剤 ・用途別分析2016年-2026年：豚、鶏肉、犬、猫、牛、馬、その他 ・動物用感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・動物用感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・動物用感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・動物用感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・動物用感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Veterinary Infectious Diseases Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Veterinary Infectious Diseases Therapeutics size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Veterinary Infectious Diseases Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Veterinary Infectious Diseases Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics

Market segment by Application can be divided into
Swine
Chicken
Dog
Cat
Cow
Horse
Other

The key market players for global Veterinary Infectious Diseases Therapeutics market are listed below:
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Veterinary Infectious Diseases Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Veterinary Infectious Diseases Therapeutics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Amebicides
1.2.6 Anthelmintics
1.3 Market Analysis by Application
1.3.1 Overview: Global Veterinary Infectious Diseases Therapeutics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Swine
1.3.3 Chicken
1.3.4 Dog
1.3.5 Cat
1.3.6 Cow
1.3.7 Horse
1.3.8 Other
1.4 Global Veterinary Infectious Diseases Therapeutics Market Size & Forecast
1.4.1 Global Veterinary Infectious Diseases Therapeutics Sales in Value (2016-2026))
1.4.2 Global Veterinary Infectious Diseases Therapeutics Sales in Volume (2016-2026)
1.4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type (2016-2026) & (USD/KG)
1.5 Global Veterinary Infectious Diseases Therapeutics Production Capacity Analysis
1.5.1 Global Veterinary Infectious Diseases Therapeutics Total Production Capacity (2016-2026)
1.5.2 Global Veterinary Infectious Diseases Therapeutics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Veterinary Infectious Diseases Therapeutics Market Drivers
1.6.2 Veterinary Infectious Diseases Therapeutics Market Restraints
1.6.3 Veterinary Infectious Diseases Therapeutics Trends Analysis
2 Manufacturers Profiles
2.1 Elanco Animal Health
2.1.1 Elanco Animal Health Details
2.1.2 Elanco Animal Health Major Business
2.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
2.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis Animal Health
2.2.1 Novartis Animal Health Details
2.2.2 Novartis Animal Health Major Business
2.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
2.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Veterinary Infectious Diseases Therapeutics Product and Services
2.3.4 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer Animal Health
2.4.1 Pfizer Animal Health Details
2.4.2 Pfizer Animal Health Major Business
2.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
2.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Product and Services
2.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Boehringer Ingelheim Vetmedica
2.6.1 Boehringer Ingelheim Vetmedica Details
2.6.2 Boehringer Ingelheim Vetmedica Major Business
2.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product and Services
2.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dechra Animal Health
2.7.1 Dechra Animal Health Details
2.7.2 Dechra Animal Health Major Business
2.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
2.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Ceva Sante Animale
2.8.1 Ceva Sante Animale Details
2.8.2 Ceva Sante Animale Major Business
2.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product and Services
2.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Elanco Animal Health
2.9.1 Elanco Animal Health Details
2.9.2 Elanco Animal Health Major Business
2.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
2.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Virbac
2.10.1 Virbac Details
2.10.2 Virbac Major Business
2.10.3 Virbac Veterinary Infectious Diseases Therapeutics Product and Services
2.10.4 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Veterinary Infectious Diseases Therapeutics Sales by Manufacturer
3.1 Global Veterinary Infectious Diseases Therapeutics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Veterinary Infectious Diseases Therapeutics
3.4 Market Concentration Rate
3.4.1 Top 3 Veterinary Infectious Diseases Therapeutics Manufacturer Market Share
3.4.2 Top 6 Veterinary Infectious Diseases Therapeutics Manufacturer Market Share
3.5 Global Veterinary Infectious Diseases Therapeutics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Veterinary Infectious Diseases Therapeutics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Region
4.1.1 Global Veterinary Infectious Diseases Therapeutics Sales in Volume by Region (2016-2026)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2016-2026)
4.2 North America Veterinary Infectious Diseases Therapeutics Revenue (2016-2026)
4.3 Europe Veterinary Infectious Diseases Therapeutics Revenue (2016-2026)
4.4 Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (2016-2026)
4.5 South America Veterinary Infectious Diseases Therapeutics Revenue (2016-2026)
4.6 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Veterinary Infectious Diseases Therapeutics Sales in Volume by Type (2016-2026)
5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2016-2026)
5.3 Global Veterinary Infectious Diseases Therapeutics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Veterinary Infectious Diseases Therapeutics Sales in Volume by Application (2016-2026)
6.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2016-2026)
6.3 Global Veterinary Infectious Diseases Therapeutics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2026)
7.2 North America Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2026)
7.3 North America Veterinary Infectious Diseases Therapeutics Market Size by Country
7.3.1 North America Veterinary Infectious Diseases Therapeutics Sales in Volume by Country (2016-2026)
7.3.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2026)
8.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2026)
8.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
8.3.1 Europe Veterinary Infectious Diseases Therapeutics Sales in Volume by Country (2016-2026)
8.3.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2026)
9.2 Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2026)
9.3 Asia-Pacific Veterinary Infectious Diseases Therapeutics Market Size by Region
9.3.1 Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2026)
10.2 South America Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2026)
10.3 South America Veterinary Infectious Diseases Therapeutics Market Size by Country
10.3.1 South America Veterinary Infectious Diseases Therapeutics Sales in Volume by Country (2016-2026)
10.3.2 South America Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2026)
11.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2026)
11.3 Middle East & Africa Veterinary Infectious Diseases Therapeutics Market Size by Country
11.3.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Veterinary Infectious Diseases Therapeutics Typical Distributors
12.3 Veterinary Infectious Diseases Therapeutics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Veterinary Infectious Diseases Therapeutics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Veterinary Infectious Diseases Therapeutics Revenue by Application, (USD Million), 2021-2026
Table 3. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Elanco Animal Health Major Business
Table 5. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
Table 6. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Animal Health Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Animal Health Major Business
Table 9. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
Table 10. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Veterinary Infectious Diseases Therapeutics Product and Services
Table 14. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Animal Health Major Business
Table 17. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
Table 18. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Veterinary Infectious Diseases Therapeutics Product and Services
Table 22. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boehringer Ingelheim Vetmedica Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Vetmedica Major Business
Table 25. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product and Services
Table 26. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dechra Animal Health Basic Information, Manufacturing Base and Competitors
Table 28. Dechra Animal Health Major Business
Table 29. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
Table 30. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 32. Ceva Sante Animale Major Business
Table 33. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product and Services
Table 34. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Elanco Animal Health Major Business
Table 37. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product and Services
Table 38. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Virbac Basic Information, Manufacturing Base and Competitors
Table 40. Virbac Major Business
Table 41. Virbac Veterinary Infectious Diseases Therapeutics Product and Services
Table 42. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturer (2019-2021e) & (KG)
Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Veterinary Infectious Diseases Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Veterinary Infectious Diseases Therapeutics Production Capacity by Company, (KG): 2020 VS 2021
Table 47. Head Office and Veterinary Infectious Diseases Therapeutics Production Site of Key Manufacturer
Table 48. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2016-2021e) & (KG)
Table 49. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2021-2026) & (KG)
Table 50. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 53. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 54. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Veterinary Infectious Diseases Therapeutics Price by Type (2016-2021e) & (USD/KG)
Table 57. Global Veterinary Infectious Diseases Therapeutics Price by Type (2021-2026) & (USD/KG)
Table 58. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 59. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 60. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Veterinary Infectious Diseases Therapeutics Price by Application (2016-2021e) & (USD/KG)
Table 63. Global Veterinary Infectious Diseases Therapeutics Price by Application (2021-2026) & (USD/KG)
Table 64. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2016-2021e) & (KG)
Table 65. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (KG)
Table 66. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 69. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 70. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 71. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 72. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2016-2021e) & (KG)
Table 73. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (KG)
Table 74. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 77. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 78. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 79. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 80. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2016-2021e) & (KG)
Table 81. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2021-2026) & (KG)
Table 82. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 85. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 86. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 87. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 88. South America Veterinary Infectious Diseases Therapeutics Sales by Country (2016-2021e) & (KG)
Table 89. South America Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (KG)
Table 90. South America Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Veterinary Infectious Diseases Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 93. South America Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 94. South America Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 95. South America Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 96. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2016-2021e) & (KG)
Table 97. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (KG)
Table 98. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2016-2021e) & (KG)
Table 101. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (KG)
Table 102. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2016-2021e) & (KG)
Table 103. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (KG)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Veterinary Infectious Diseases Therapeutics Typical Distributors
Table 107. Veterinary Infectious Diseases Therapeutics Typical Customers
List of Figures
Figure 1. Veterinary Infectious Diseases Therapeutics Picture
Figure 2. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2020
Figure 3. Antibiotics
Figure 4. Antiviral
Figure 5. Antifungal
Figure 6. Amebicides
Figure 7. Anthelmintics
Figure 8. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2020
Figure 9. Swine
Figure 10. Chicken
Figure 11. Dog
Figure 12. Cat
Figure 13. Cow
Figure 14. Horse
Figure 15. Other
Figure 16. Global Veterinary Infectious Diseases Therapeutics Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 17. Global Veterinary Infectious Diseases Therapeutics Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Veterinary Infectious Diseases Therapeutics Sales (2016-2026) & (KG)
Figure 38. Global Veterinary Infectious Diseases Therapeutics Production Capacity (2016-2026) & (KG)
Figure 39. Global Veterinary Infectious Diseases Therapeutics Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Veterinary Infectious Diseases Therapeutics Market Drivers
Figure 41. Veterinary Infectious Diseases Therapeutics Market Restraints
Figure 42. Veterinary Infectious Diseases Therapeutics Market Trends
Figure 43. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturer in 2020
Figure 44. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturer in 2020
Figure 45. Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Veterinary Infectious Diseases Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Veterinary Infectious Diseases Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2016-2026)
Figure 49. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2016-2026)
Figure 50. North America Veterinary Infectious Diseases Therapeutics Revenue (2016-2026) & (USD Million)
Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (2016-2026) & (USD Million)
Figure 53. South America Veterinary Infectious Diseases Therapeutics Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue (2016-2026) & (USD Million)
Figure 55. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2016-2026)
Figure 57. Global Veterinary Infectious Diseases Therapeutics Price by Type (2016-2026) & (USD/KG)
Figure 58. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 59. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2016-2026)
Figure 60. Global Veterinary Infectious Diseases Therapeutics Price by Application (2016-2026) & (USD/KG)
Figure 61. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2016-2026)
Figure 62. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2016-2026)
Figure 63. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2016-2026)
Figure 66. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2016-2026)
Figure 68. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 73. South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2016-2026)
Figure 74. South America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2016-2026)
Figure 75. South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2016-2026)
Figure 76. South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

---